IP Verse

Rinat Neuroscience competitive analysis

Latest patents of Rinat Neuroscience opposed by its competitors

Explore Rinat Neuroscience's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Aug 27, 2026
Patent NumberPublication DateTitleTotal Oppositions
EP2100902
Dec 18, 2019Methods For Treating Pain By Administering An Antagonist Antibody Against The Nerve Growth Factor And An Opioid Analgesic, And Compositions Containing The Same1
EP2206728
Oct 10, 2018Methods For Treating Bone Cancer Pain By Administering A Nerve Growth Factor Antagonistic Antibody1
EP2305711
Aug 2, 2017Methods For Treating Osteoarthitis Pain By Administering A Nerve Growth Factor Antagonist And Compositions Containing The Same2
EP2270048
Nov 11, 2015Anti-Ngf Antibodies And Methods Using Same4

Latest PTAB cases involving Rinat Neuroscience

Discover the latest PTAB cases involving Rinat Neuroscience, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Rinat Neuroscience with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Aug 27, 2026
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
RINAT NEUROSCIENCE - 8 - -
JAMES POOLE204 - - -
REGENERON PHARMACEUTICALS55148932
TEVA PHARMACEUTICAL INDUSTRIES LTD2727 - -